Multiple Dose Safety Study of NPT088 in Patients With Mild to Moderate Probable Alzheimer's Disease

Completed · Phase 1 · Has a placebo group

Conditions studied: Alzheimer Disease

In brief

The purpose of the study is to evaluate the safety and tolerability of multiple doses of NPT088 in patients with mild to moderate probable Alzheimer's Disease. The study will also evaluate the pharmacokinetics, immunogenicity and exploratory pharmacodynamic characteristics of multiple doses of NPT088.

Key facts

Study ID
NCT03008161
Run by
Proclara Biosciences, Inc.
People needed
83
Starts
2016-12-01
Expected to finish
2019-02-06
Last updated by the study team
2019-08-15

Who can join

Age: 50 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.